These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30698174)

  • 21. The stoichiometric production of IL-2 and IFN-γ mRNA defines memory T cells that can self-renew after adoptive transfer in humans.
    Wang A; Chandran S; Shah SA; Chiu Y; Paria BC; Aghamolla T; Alvarez-Downing MM; Lee CC; Singh S; Li T; Dudley ME; Restifo NP; Rosenberg SA; Kammula US
    Sci Transl Med; 2012 Aug; 4(149):149ra120. PubMed ID: 22932225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TransCon IL-2 β/γ: a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic immune cells for the treatment of cancer.
    Rosen DB; Kvarnhammar AM; Laufer B; Knappe T; Karlsson JJ; Hong E; Lee YC; Thakar D; Zúñiga LA; Bang K; Sabharwal SS; Uppal K; Olling JD; Kjaergaard K; Kurpiers T; Schnabel M; Reich D; Glock P; Zettler J; Krusch M; Bernhard A; Heinig S; Konjik V; Wegge T; Hehn Y; Killian S; Viet L; Runz J; Faltinger F; Tabrizi M; Abel KL; Breinholt VM; Singel SM; Sprogøe K; Punnonen J
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35817480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice.
    Klebanoff CA; Gattinoni L; Palmer DC; Muranski P; Ji Y; Hinrichs CS; Borman ZA; Kerkar SP; Scott CD; Finkelstein SE; Rosenberg SA; Restifo NP
    Clin Cancer Res; 2011 Aug; 17(16):5343-52. PubMed ID: 21737507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses.
    Song S; Jin X; Zhang L; Zhao C; Ding Y; Ang Q; Khaidav O; Shen C
    Int J Nanomedicine; 2019; 14():2465-2483. PubMed ID: 31040669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-responsive nanogel as IL-12 carrier for anti-cancer therapy.
    Zhang C; Li Q; Wu C; Wang J; Su M; Deng J
    Nanotechnology; 2021 Feb; 32(9):095107. PubMed ID: 33238258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-Functional Nanogels for Tumor Targeting and Redox-Sensitive Drug and siRNA Delivery.
    Adamo G; Grimaldi N; Campora S; Bulone D; Bondì ML; Al-Sheikhly M; Sabatino MA; Dispenza C; Ghersi G
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27886088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cells from tumor-immune mice nonspecifically expanded in vitro with anti-CD3 plus IL-2 retain specific function in vitro and can eradicate disseminated leukemia in vivo.
    Crossland KD; Lee VK; Chen W; Riddell SR; Greenberg PD; Cheever MA
    J Immunol; 1991 Jun; 146(12):4414-20. PubMed ID: 1674958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective melanoma immunotherapy with interleukin-2 delivered by a novel polymeric nanoparticle.
    Yao H; Ng SS; Huo LF; Chow BK; Shen Z; Yang M; Sze J; Ko O; Li M; Yue A; Lu LW; Bian XW; Kung HF; Lin MC
    Mol Cancer Ther; 2011 Jun; 10(6):1082-92. PubMed ID: 21518728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Redox-Responsive Nanogel with Intracellular Reconstruction and Programmable Drug Release for Targeted Tumor Therapy.
    Tian Y; Tian R; Chen L; Jin R; Feng Y; Bai Y; Chen X
    Macromol Rapid Commun; 2019 Apr; 40(8):e1800824. PubMed ID: 30779386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model.
    Yang S; Archer GE; Flores CE; Mitchell DA; Sampson JH
    Cancer Immunol Immunother; 2013 Nov; 62(11):1649-62. PubMed ID: 23982483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-cancer vaccination by transdermal delivery of antigen peptide-loaded nanogels via iontophoresis.
    Toyoda M; Hama S; Ikeda Y; Nagasaki Y; Kogure K
    Int J Pharm; 2015 Apr; 483(1-2):110-4. PubMed ID: 25681719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-adjuvanted L-arginine-modified dextran-based nanogels for sustained local antigenic protein delivery to antigen-presenting cells and enhanced cellular and humoral immune responses.
    Chung JT; Rafiei M; Chau Y
    Biomater Sci; 2024 Mar; 12(7):1771-1787. PubMed ID: 38385306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resveratrol prevents endothelial cells injury in high-dose interleukin-2 therapy against melanoma.
    Guan H; Singh NP; Singh UP; Nagarkatti PS; Nagarkatti M
    PLoS One; 2012; 7(4):e35650. PubMed ID: 22532866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted nanogels: a versatile platform for drug delivery to tumors.
    Murphy EA; Majeti BK; Mukthavaram R; Acevedo LM; Barnes LA; Cheresh DA
    Mol Cancer Ther; 2011 Jun; 10(6):972-82. PubMed ID: 21518727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy.
    Lopes JE; Fisher JL; Flick HL; Wang C; Sun L; Ernstoff MS; Alvarez JC; Losey HC
    J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32317293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B cells imprint adoptively transferred CD8
    Smith AS; Knochelmann HM; Wyatt MM; Rangel Rivera GO; Rivera-Reyes AM; Dwyer CJ; Ware MB; Cole AC; Neskey DM; Rubinstein MP; Liu B; Thaxton JE; Bartee E; Paulos CM
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models.
    Charych DH; Hoch U; Langowski JL; Lee SR; Addepalli MK; Kirk PB; Sheng D; Liu X; Sims PW; VanderVeen LA; Ali CF; Chang TK; Konakova M; Pena RL; Kanhere RS; Kirksey YM; Ji C; Wang Y; Huang J; Sweeney TD; Kantak SS; Doberstein SK
    Clin Cancer Res; 2016 Feb; 22(3):680-90. PubMed ID: 26832745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
    Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
    Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual responsive nanogels for intracellular doxorubicin delivery.
    Asadi H; Khoee S
    Int J Pharm; 2016 Sep; 511(1):424-435. PubMed ID: 27444549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells.
    Klebanoff CA; Finkelstein SE; Surman DR; Lichtman MK; Gattinoni L; Theoret MR; Grewal N; Spiess PJ; Antony PA; Palmer DC; Tagaya Y; Rosenberg SA; Waldmann TA; Restifo NP
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1969-74. PubMed ID: 14762166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.